Xgeva 120mg Injection

Xgeva 120 mg Injection contains denosumab, a monoclonal antibody used to manage bone-related conditions by reducing bone breakdown and strengthening bones, especially in patients at high risk of fractures or bone complications. It works by blocking RANKL, a key protein involved in bone resorption, helping improve bone density and reduce bone loss. Administered as a subcutaneous injection under medical supervision, patients are often advised to take calcium and vitamin D supplements during treatment. Common side effects include bone, joint, or muscle pain and urinary infections, while serious but rare risks such as low calcium levels, jaw bone problems, or fractures require prompt medical attention and regular monitoring.